O'Reilly S M, Camplejohn R S, Barnes D M, Millis R R, Allen D, Rubens R D, Richards M A
ICRF Clinical Oncology Unit, Guy's Hospital, London, UK.
Br J Cancer. 1990 May;61(5):671-4. doi: 10.1038/bjc.1990.152.
DNA index and S-phase fraction (SPF) were measured by flow cytometry on paraffin embedded tissue from 140 primary breast tumours. The results of DNA analysis were compared with the size, degree of axillary node involvement, histological grade and steroid receptor content of the tumours, as well as with the patients' subsequent clinical course. Forty-four (31.4%) of the 140 tumours were diploid. S-phase fraction was evaluable for 134 (95.7%). The median SPF of the whole population was 7.1%, with diploid tumours having a significantly lower median SPF (3.2%) than aneuploid (10.1%, P less than 0.001). Both aneuploidy (P = 0.002) and high SPF (P less than 0.001) were strongly associated with high histological grade. There was no significant association between either DNA ploidy or SPF and tumour size, nodal status or steroid receptor content. An SPF below the median was strongly associated with better relapse-free survival (P = 0.008), overall survival (P = 0.004) and survival after relapse (P less than 0.001). Ploidy did not correlate significantly with clinical course. Multivariate analysis using the Cox model suggested that, while SPF gave prognostic information independent of tumour size or nodal status, this independent significance was lost when histological grade was included in the analysis.
采用流式细胞术对140例原发性乳腺肿瘤石蜡包埋组织进行DNA指数和S期细胞分数(SPF)检测。将DNA分析结果与肿瘤的大小、腋窝淋巴结受累程度、组织学分级、类固醇受体含量以及患者随后的临床病程进行比较。140例肿瘤中有44例(31.4%)为二倍体。134例(95.7%)可评估S期细胞分数。总体人群的中位SPF为7.1%,二倍体肿瘤的中位SPF(3.2%)显著低于非整倍体肿瘤(10.1%,P<0.001)。非整倍体(P=0.002)和高SPF(P<0.001)均与高组织学分级密切相关。DNA倍体或SPF与肿瘤大小、淋巴结状态或类固醇受体含量之间均无显著相关性。SPF低于中位数与更好的无复发生存率(P=0.008)、总生存率(P=0.004)和复发后生存率(P<0.001)密切相关。倍体与临床病程无显著相关性。使用Cox模型进行多变量分析表明,虽然SPF提供了独立于肿瘤大小或淋巴结状态的预后信息,但当分析中纳入组织学分级时,这种独立意义就丧失了。